A comparison of hexabrix and Renografin 60 in peripheral arteriography.
Fifty-one patients were analyzed after a randomized double-blind study comparing Hexabrix and Renografin 60 in peripheral arteriography. The arteriographic studies and the volumes of contrast material used in both groups were similar. Hexabrix caused significantly less pain and discomfort than Renografin 60, and the diagnostic quality of the radiographs was comparable. A slightly higher incidence of minor side effects was noted in the Hexabrix group, mostly nausea and vomiting and urinary retention.
D000792:Angiography; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging*; D003287:Contrast Media; D003973:Diatrizoate / Q000009:adverse effects / Q000031:analogs & derivatives; D003974:Diatrizoate Meglumine / Q000009:adverse effects; D004311:Double-Blind Method; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects; D007485:Ioxaglic Acid; D008297:Male; D010146:Pain / Q000209:etiology; D011897:Random Allocation; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D003287:Contrast Media; D004338:Drug Combinations; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; C027278:urovision; D007485:Ioxaglic Acid